Area of research
Biotechnology · Biomedical Engineering
Research interest
Research interests include Cancer Research and Treatments, Nanoplatforms for cancer theranostics, Virus-based gene therapy research, and Hepatocellular Carcinoma Treatment and Prognosis.
Hepatocellular carcinoma surveillance: a health economic evaluation
Beyond diagnostic accuracy: Economic and clinical considerations for NC-MRI in late HCC recurrence surveillance: Letter to the editor on “Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography”
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition)
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition)
The Synergistic Mechanisms and Prospects of Transarterial Chemoembolization Combined with Immunotherapy for Hepatocellular Carcinoma.
Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus.
Children's hepatoblastoma: gender and infant age demand focus in the global burden of disease study 2021.
TACE-HAIC versus TACE as Initial Regional Therapy for Unresectable Huge Hepatocellular Carcinoma (>10 cm): A Propensity Score-Matched Study.
Epidemiology of respiratory pathogens in patients with acute respiratory infections during the COVID‐19 pandemic and after easing of COVID‐19 restrictions
Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.
Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma.
Transarterial chemoembolization for hepatocellular carcinoma: Treatment algorithm proposed by Chinese College of Interventionalists (CCI)
Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition)
Improving the Conversion Success Rate of Hepatocellular Carcinoma: Focus on the Use of Combination Therapy with a High Objective Response Rate.
Recommended 10-Year Follow-Up Strategy for Small Hepatocellular Carcinoma After Radiofrequency Ablation: A Cost-Effectiveness Evaluation.
Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: Multicenter, real-world study.
Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: A treatment dilemma-Authors' reply.
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations
Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1).
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer
Nomogram Based on CT Radiomics Features Combined With Clinical Factors to Predict Ki-67 Expression in Hepatocellular Carcinoma
TALENTACE: A phase III, open-label, randomized study of on-demand transarterial chemoembolization combined with atezolizumab + bevacizumab or on-demand transarterial chemoembolization alone in patients with untreated hepatocellular carcinoma.
Immunotherapy in older patients with hepatocellular carcinoma.
Effect and Safety of Prophylactic Parecoxib for Pain Control of Transarterial Chemoembolization in Liver Cancer: A Single-Center, Parallel-Group, Randomized Trial.
Reply to O. Sütcüoğlu et al.
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin
SCC-PG: Getting the Edge on Data-Driven Self-Managed Care: A Focus on Older Veterans in Arizona
IUCRC Phase II Arizona State University: Center for Accelerated Real Time Analytics (CARTA)
CC* Integration-Large: (BLUE) Software-Defined CyberInfrastructure to enable data-driven smart campus applications
CNS Core: Medium: Collaborative Research: Generalized Caching-As-A-Service
II-NEW: GEARS - An Infrastructure for Energy-Efficient Big Data Research on Heterogeneous and Dynamic Data
CSR: Medium: Collaborative Research: NVM-enabled Host-side Caches
CAREER: Coordinated QoS-Driven Management of Cloud Computing and Storage Resources
Student Travel Support for ACM HPDC 2015
CAREER: Coordinated QoS-Driven Management of Cloud Computing and Storage Resources
HECURA: Collaborative Research: QoS-driven Storage Management for High-end Computing Systems